Patents by Inventor Weizhou Zhang

Weizhou Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1 (NR4A1) AND USES THEREOF
    Publication number: 20230330237
    Abstract: Modulators of Nuclear Receptor Subfamily 4 Group A Member 1 (NR4A1) are described as well as their use as therapeutic agents for disease, disorders, or symptoms thereof, including those where modulation of NR4A1 is implicated. Such disease and disorders include cancer.
    Type: Application
    Filed: August 27, 2021
    Publication date: October 19, 2023
    Applicant: University of Florida Research Foundation, Incorporated
    Inventors: Weizhou Zhang, Guangrong Zheng, Daohong Zhou, Yufeng Xiao, Lei Wang
  • ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE
    Publication number: 20220389088
    Abstract: Described herein are anti-angiopoictin-like 4 (ANGPTL4) antibodies and methods of treating disorders associated with elevated expression of ANGPTL4. In one aspect, described herein is an antibody or antigen binding fragment thereof that binds angiopoietin-like 4 (ANGPTL4) comprising amino acid sequences set forth in (a) SEQ ID NOs: 3-8 (Ab-A CDRs), (b) SEQ ID NOs: 13-18 (Ab-B CDRs), (c) SEQ ID NOs: 23-28 (Ab-C CDRs), (d) SEQ ID NOs: 33-38 (Ab-D CDRs), or (e) SEQ ID NOs: 43-48 (Ab-E CDRs).
    Type: Application
    Filed: October 29, 2020
    Publication date: December 8, 2022
    Inventors: Weizhou Zhang, Ryan Harrison Kolb